Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Monday
May 09
10:30 - 11:30
Auditorium 11
Novel approaches towards IGRT
Cristina Garibaldi, Italy;
Lucie Calmels, France
3220
Proffered Papers
Physics
11:20 - 11:30
Parametrization of artery delineation and nationwide implementation in the DBCG RT Nation cohort
Emma Skarsø Buhl, Denmark
OC-0780

Abstract

Parametrization of artery delineation and nationwide implementation in the DBCG RT Nation cohort
Authors:

Emma Riis Skarsø1, Lasse Hindhede Refsgaard1, Thomas Ravkilde2, Henrik Dahl Nissen3, Martin Berg3, Kristian Boye4, Claus Kamby5, Kirsten Jakobsen6, Mikael Olesen6, Birgitte Vrou Offersen1,2,7, Stine Sofia Korreman1,2,7

1Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus N, Denmark; 2Aarhus University Hospital, Department of Oncology, Aarhus N, Denmark; 3Vejle Hospital, University Hospital of Southern Denmark, Department of Oncology, Vejle, Denmark; 4Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Copenhagen, Denmark; 5Copenhagen University Hospital - Rigshospitalet, Department of Oncology, Copenhagen, Denmark; 6Zealand University Hospital, Department of Clinical Oncology and Palliative Care, Næstved, Denmark; 7Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus N, Denmark

Show Affiliations
Purpose or Objective

Delineation of structures of limited visibility and small size is prone to large uncertainties. With adaptive treatment planning and automatic delineation making its entry in clinical routine, it is desirable to have a framework for quality assurance (QA) of delineation of such structures. In this study we develop a parameterization of left anterior descending coronary artery (LADCA) delineation. We test the method in a national dataset.

Material and Methods

We included structure delineations from 4598 danish high-risk breast cancer patients treated with adjuvant radiotherapy across the nation during 2008-2017. A national LADCA delineation guideline was published in 2013. The coordinate sets of the individual delineations were exported and analysed in python (v 3.9.6). LADCA was parameterized using metrics describing volume, cranial-caudal (CC) length, the cumulative length, width, anterior-posterior and lateral-medial consistency between slices, missing structure slices and number of patients with delineations.

The cumulative length was determined by summing the vector-distance between consecutive centroid points in all CT slices. The x and y centroid values were calculated by averaging all x- and y-coordinates respectively. If the distance between two adjacent centroid points was > 80 mm, the point was removed from the calculation as an outlier.

The width was determined by scaling the horizontal width by cos(), where  is the angle between the horizontal and scaled width, Figure 1.

Results were stratified by year and treating center. Significance was tested with the Mann-Whitney U-test.

Results

The automatic method was successfully used in all patients included in the Danish Breast Cancer Group (DBCG) RT Nation cohort.

In total 2018 (44%) of patients had LADCA delineated. Distribution per center including number of missing slices is shown below. 


# patients included (% of total # patients)
# patients with LADCA delineations (% of total # LADCA delineations)
Total # missing slices
Center 11132 (25%)
579 (29%)
31
Center 2922 (20%)
320 (16%)
5
Center 31802 (39%)
676 (33%)
20
Center 4742 (16%)
443 (22%)
54

In the period around the implementation of national delineation guidelines (2012-2014), the differences between the centers were smallest, Figure 2. For mean width there was a significant difference between centers in the periods 2008-2012 and 2014-2017 (p<0.001). For CC length, no significant differences were found between center 2 and 3 (2011-2016). Center 4 differed significantly from the other centers in CC length in the periods 2010-2011 and 2015-2017 (p<0.001). 


  


Conclusion

We have developed a method for parametrization of delineations of LADCA. We have successfully used the method for characterization of LADCA delineations in a national DBCG patient cohort. Our results showed significant differences in delineations of LADCA among centers and need for regularly QA regarding delineations. This method has potential as a metric for QA, and to be generalizable for other tubular structures.